Precision Transfusion Management: Rh Phenotype Compatibility and Antibody Surveillance in Southern China
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective
To analyze Rh antigen (C, c, D, E, e) distribution and alloimmunization patterns in Hengyang, China, and establish precision transfusion strategies.
Methods
Rh phenotyping and antibody screening were performed on 3,635 hospitalized patients and 5,326 donors using serological cards. A transfusion management system tracked historical antibodies and flagged discrepancies.
Results
Antigen frequencies in patients were D (99.56%) > e (94.69%) > C (91.64%) > c (48.06%) > E (38.79%). Dominant Rh(D)-positive phenotypes included CCDee (51.31%) and CcDEe (30.01%). After implementing Rh-matched transfusions (March–October 2023), antibody screening positivity decreased from 1.14% (2022) to 0.97% (p < 0.05). Rh system antibodies accounted for 46.01% (127/276) of positives in 2023, down from 55.21% in 2022 (p < 0.05), and were the leading cause of crossmatch incompatibility.
Conclusion
Rh antigen-matched transfusions significantly reduce alloimmunization risks. Continuous antibody tracking via transfusion management systems enhances transfusion safety.
